10.1002/adma.201905823 10 DixonS
The company will discontinue advertising compounded GLP-1 products, while Novo Nordisk has reserved the right to pursue legal action in the future if needed
The two predominant PUFAs in the brain are omega-3 fatty acid docosahexaenoic acid (DHA) and omega-6 fatty acid arachidonic acid (AA)
for example, improved contractile performance ( 2 and local muscle O 2 delivery and extraction in elite endurance athletes ( ingestion did not increase the performance of endurance runners in normobaric hypoxia
DingYDaiXBaoMXingYLiuJZhaoSet al
The goal should not simply be weight loss, but improved long-term health, function, and quality of life GLP-1 medications offer promising benefits for physical health and may positively influence mental health through mood improvement, cognitive support, and appetite regulation